Loading company…
MediFab develops 3D cell culture systems and biomaterial implants for tissue repair and research.
Founded in 2016 and based in Seoul, MediFab develops and manufactures biomaterial products using tissue repair and 3D printing technologies. Its Cellrix 3D culture system supports research including stem cell, spheroid, and cancer studies by creating an implantable 3D cell environment. The company has conducted research and development collaborations with Seoul Boramae Hospital and Seoul National University.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in